The History of Opiate Treatment Expansion
Author Information
Author(s): Robert G Newman
Primary Institution: The Baron Edmond de Rothschild Chemical Dependency Institute of Beth Israel Medical Center, Albert Einstein College of Medicine of Yeshiva University
Hypothesis
Will buprenorphine fulfill its potential in treating opiate addiction?
Conclusion
The success of buprenorphine in treating opiate addiction depends on government commitment to provide care to all who need it.
Supporting Evidence
- Buprenorphine can be prescribed by independent practitioners, unlike methadone.
- The New York City Health Department program had an active enrollment of approximately 11,000.
- Government support is crucial for the success of addiction treatments.
Takeaway
This article talks about how a new medicine called buprenorphine can help people with opiate addiction, but we need the government to help make sure everyone can get it.
Potential Biases
There is a risk of bias due to the stigma associated with methadone treatment affecting the acceptance of buprenorphine.
Limitations
The article discusses the lack of significant increase in addiction treatment capacity since the 1970s.
Participant Demographics
The article references the heroin-dependent population in New York City.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website